CoChat

Who attends a UK diabetes screening programme? Findings from the ADDITION‐Cambridge study

Open access
Sargeant, L. A., Simmons, R. K., Barling, R. S., Butler, R., Williams, K. M., Prevost, A. T., Kinmonth, A. L., Wareham, N. J., Griffin, S. J. · 2010 · Diabetic Medicine
Cited by 61

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Diabet. Med. 27, 995–1003 (2010) Aims One of the factors influencing the cost‐effectiveness of population screening for Type 2 diabetes may be uptake. We examined attendance and practice‐ and individual‐level factors influencing uptake at each stage of a diabetes screening programme in general practice. Methods A stepwise screening programme was undertaken among 135 825 people aged 40–69 years without known diabetes in 49 general practices in East England. The programme included a score based on routinely available data (age, sex, body mass index and prescribed medication) to identify those at high risk, who were offered random capillary blood glucose (RBG) and glycosylated haemoglobin tests. Those screening positive were offered fasting capillary blood glucose (FBG) and confirmatory oral glucose tolerance tests (OGTT). Results There were 33 539 high‐risk individuals invited for a RBG screening test; 24 654 (74%) attended. Ninety‐four per cent attended the follow‐up FBG test and 82% the diagnostic OGTT. Seventy per cent of individuals completed the screening programme. Practices with higher general practitioner staff complements and those located in more deprived areas had lower uptake for RBG and FBG tests. Male sex and a higher body mass index were associated with lower attendance for RBG testing. Older age, prescription of antihypertensive medication and a higher risk score were associated with higher attendance for FBG and RBG tests. Conclusions High attendance rates can be achieved by targeted stepwise screening of individuals assessed as high risk by data routinely available in general practice. Different strategies may be required to increase initial attendance, ensure completion of the screening programme, and reduce the risk that screening increases health inequalities.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1464-5491.2010.03056.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 61

Metadata

Authors
Sargeant, L. A., Simmons, R. K., Barling, R. S., Butler, R., Williams, K. M., Prevost, A. T., Kinmonth, A. L., Wareham, N. J., & Griffin, S. J.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2010-08-18
Volume
27
Issue
9
Pages
995-1003
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W1867797704
Cited by
61
References
3
FWCI
7.45
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Who attends a UK diabetes screening programme? Findings from the ADDITION‐Cambridge study. https://app.cochat.ai/papers/10.1111/j.1464-5491.2010.03056.x
The paper
Sargeant, L. A., Simmons, R. K., Barling, R. S., Butler, R., Williams, K. M., Prevost, A. T., Kinmonth, A. L., Wareham, N. J., & Griffin, S. J. (2010). Who attends a UK diabetes screening programme? Findings from the ADDITION‐Cambridge study. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2010.03056.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.